These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8399893)

  • 1. Onset of life-threatening ventriculitis during ceftazidime therapy for nosocomial pneumonia due to Enterobacter cloacae.
    Land G; Salgado J; Greenberg RN
    Clin Infect Dis; 1993 Aug; 17(2):295-6. PubMed ID: 8399893
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of ciprofloxacin in an infant with ventriculitis.
    Goepp JG; Lee CK; Anderson T; Dick JD; Stokoe JM; Eiden J
    J Pediatr; 1992 Aug; 121(2):303-5. PubMed ID: 1640304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous ciprofloxacin versus ceftazidime for treatment of nosocomial pneumonia and urinary tract infection.
    Rapp RP; Billeter M; Hatton J; Young AB; Tibbs PA; Dempsey RJ
    Clin Pharm; 1991 Jan; 10(1):49-55. PubMed ID: 1999086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature.
    Barnes BJ; Wiederhold NP; Micek ST; Polish LB; Ritchie DJ
    Pharmacotherapy; 2003 Apr; 23(4):537-42. PubMed ID: 12680484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone versus ceftazidime monotherapy of nosocomial pneumonia.
    Mangi RJ; Ryan J; Berenson C; Greco T; Simms M; Thornton G; Andriole VT
    Am J Med; 1988 Jul; 85(1A):44-8. PubMed ID: 3041818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin.
    Cascio A; Mezzatesta ML; Odierna A; Di Bernardo F; Barberi G; Iaria C; Stefani S; Giordano S
    Int J Infect Dis; 2014 Mar; 20():66-7. PubMed ID: 24412601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the effectiveness of ceftazidime in treatment of nosocomial infections in children].
    Czerwionka-Szaflarska M; Sobkowiak E
    Pediatr Pol; 1996 Jul; 71(7):605-7. PubMed ID: 8803464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrobacter diversus ventriculitis and brain abscesses in an adult.
    Booth LV; Palmer JD; Pateman J; Tuck AC
    J Infect; 1993 Mar; 26(2):207-9. PubMed ID: 8473769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of multidrug-resistant Enterobacter cloacae: nosocomial outbreak or change of microbial ecology?
    Honderlick P; Saheb F; Cahen P
    Pathol Biol (Paris); 1999 May; 47(5):437-9. PubMed ID: 10418014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.
    Quinn JP; DiVincenzo CA; Foster J
    J Infect Dis; 1987 May; 155(5):942-7. PubMed ID: 3549922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple beta-lactam resistance in Enterobacter cloacae following ceftazidime monotherapy.
    Black AS; Cohen J
    Lancet; 1985 Aug; 2(8450):331-2. PubMed ID: 2862496
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nosocomial infections with resistant Enterobacter cloacae. Effects on the disease and the treatment].
    Olafsen K; Hotvedt R; Andersen BM; Almdahl SM; Sørlie D
    Tidsskr Nor Laegeforen; 1989 Jan; 109(3):332-6. PubMed ID: 2916217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increased incidence of Enterobacter cloacae in a cardiovascular ward.
    Kanemitsu K; Endo S; Oda K; Saito K; Kunishima H; Hatta M; Inden K; Kaku M
    J Hosp Infect; 2007 Jun; 66(2):130-4. PubMed ID: 17512633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
    Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I integron-borne bla(VIM-1) carbapenemase in a strain of Enterobacter cloacae responsible for a case of fatal pneumonia.
    Perilli M; Mezzatesta ML; Falcone M; Pellegrini C; Amicosante G; Venditti M; Stefani S
    Microb Drug Resist; 2008 Mar; 14(1):45-7. PubMed ID: 18321204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDM-1 encoded by a pNDM-HN380-like plasmid pNDM-BJ03 in clinical Enterobacter cloacae.
    Lü Y; Liu W; Liang H; Zhao S; Zhang W; Liu J; Jin C; Hu H
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):153-155. PubMed ID: 29195767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial septicaemia due to Enterobacter cloacae.
    Commun Dis Rep CDR Wkly; 1994 Apr; 4(17):77. PubMed ID: 7516785
    [No Abstract]   [Full Text] [Related]  

  • 18. Nontraumatic pneumocephalus due to nosocomial Enterobacter cloacae infection.
    Kuo CC; Wang JY; Chien JY; Chen YF; Wu VC; Tsai CW; Hwang JJ
    Diagn Microbiol Infect Dis; 2010 Jan; 66(1):108-10. PubMed ID: 19442474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of ceftriaxone versus ceftazidime in the treatment of nosocomial lower respiratory tract infections.
    Bassetti D; Cruciani M; Solbiati M; Rubini F; Gandola L; Valenti G; De Palma M; Corda R; Carimeo N
    Chemotherapy; 1991; 37(5):371-5. PubMed ID: 1804598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
    Mimoz O; Jacolot A; Padoin C; Tod M; Samii K; Petitjean O
    J Antimicrob Chemother; 1998 Mar; 41(3):367-72. PubMed ID: 9578163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.